Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products, such as irrigation, first-aid solution, and eye lubricants in medical device segment. It also offers a wide range of closure systems, such as nipple head, twist-off, leur-lock, and screw types and container fill-volume ranging from 2ml to 1000 ml. Its markets its products through three strategic business units including national sales, international sales, and product partnering wit
| Current Price | ₹164.88 |
|---|---|
| Market Cap | ₹712 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 37.9 |
| Return on Equity | 6.76% |
| 52-Week Range | ₹92.00 – ₹209.95 |
| Beta (1Y) | 0.3 |
| Revenue | ₹69 Cr |
|---|---|
| Net Profit | ₹3 Cr |
| EPS (Basic) | ₹0.85 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
1. Manufacturing and sale of pharmaceutical products-100%
Amanta Healthcare Limited is trading at ₹164.88, with a market capitalisation of ₹712 Cr.
Amanta Healthcare Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
Amanta Healthcare Limited has a P/E of 37.9 and a return on equity of 6.76%.
In Q1 FY27, Amanta Healthcare Limited reported revenue of ₹69 Cr and net profit of ₹3 Cr, with basic EPS of ₹0.85 (standalone, parsed from the company's exchange filing).